Kiora PharmaceuticalsKPRX
13F holders, Q3 2024 (September 30)1holders −1
0new positions
1sold out
$3.66avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Kiora Pharmaceuticals Inc. (KPRX) in their 13F filings, down 1 from Q2 2024. 0 opened new positions and 1 sold out. The largest holder was Rosalind Advisors, Inc. ($935K).
- Company
- Kiora Pharmaceuticals Inc.
- CUSIP
- 49721T309
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $840K |
All 13F filers, Q2 2024 → Q3 2024: 200,000 shares sold, net −200,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Rosalind Advisors, Inc. | 0.62% | No change | 255,555 | $935K |
"% of holder's portfolio" is KPRX's weight in each manager's 13F, not the share of Kiora Pharmaceuticals Inc. the manager owns.